Anzeige
Mehr »
Dienstag, 26.08.2025 - Börsentäglich über 12.000 News
Breaking: AlsetAI zündet nächste Stufe - Neue Allianz mit CHIP Datacentres & Hochkarätige Vorstände markieren Wendepunkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
138 Leser
Artikel bewerten:
(0)

DataM Intelligence 4 Market Research LLP: Cosmetic Surgery Market Size worth US$ 73.09 billion by 2033 with 7.9% CAGR, Report by DataM Intelligence

HYDERABAD, India, Aug. 26, 2025 /PRNewswire/ -- According to DataM Intelligence, the global cosmetic surgery market size reached US$ 35.86 Billion in 2024 and is expected to reach US$ 73.09 Billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033.

DataM Intelligence Logo

Cosmetic surgery is undergoing a global transformation, driven by rising aesthetic awareness, technological innovation, and shifting cultural attitudes toward beauty enhancement. From non-invasive treatments like injectables and laser-based therapies to advanced surgical procedures, demand is accelerating across diverse age groups and geographies. Increasing disposable income, the influence of social media, and broader accessibility to aesthetic procedures are fueling growth, particularly in emerging economies. At the same time, breakthroughs in safety, personalization, and recovery times are attracting a wider demographic. As competition intensifies and consumer expectations evolve, businesses operating in or entering the aesthetic space must stay ahead of fast-changing trends. Access to deep, data-backed insights is critical for capturing growth, identifying unmet needs, and navigating regulatory landscapes in this highly dynamic field. This report provides strategic intelligence to capitalize on one of the most resilient and fast-evolving segments in global healthcare and wellness.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/cosmetic-surgery-market

Surge in Non-Surgical Treatments

Minimally invasive procedures, such as botulinum toxin injections, dermal fillers, and chemical peels, are at the forefront of the cosmetic surgery market's growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, approximately 13.3 million minimally invasive procedures were performed, accounting for a significant portion of the 15.6 million total cosmetic procedures. These treatments offer shorter recovery times, reduced risks, and affordability, making them highly attractive to consumers. The growing preference for non-surgical options is expected to continue driving market growth throughout the forecast period.

Benefits of Minimally Invasive Techniques

The appeal of minimally invasive procedures lies in their ability to deliver noticeable results with minimal discomfort and downtime. These treatments cater to busy lifestyles, allowing patients to resume daily activities quickly. Innovations in laser-based therapies and injectables have further enhanced the safety and efficacy of these procedures, broadening their adoption across diverse markets.

Breast Augmentation Leads with 36.5% Market Share

The mammoplasty procedure segment, particularly breast augmentation and reduction, accounted for 36.5% of the market share in 2024 and is expected to dominate through 2033. Breast reduction surgery, or reduction mammaplasty, removes excess breast fat, tissue, and skin to alleviate discomfort and enhance appearance for individuals with large breasts. In 2021, ASPS reported 365,000 breast augmentations, with 148,000 women opting for implant replacement and 71,000 choosing implant removal without replacement. The popularity of mammoplasty reflects its dual benefits of aesthetic improvement and physical comfort, driving its significant market presence.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/5g-in-healthcare-market

North America Holds 40.7% Market Share

North America accounted for 40.7% of the global cosmetic surgery market in 2024, driven by a strong focus on external aesthetics, widespread acceptance of cosmetic procedures, and advancements in technology. The region's dominance is supported by a robust healthcare infrastructure and a high volume of both surgical and non-surgical procedures. ASPS data indicates that surgical procedures accounted for 54% of treatments, while non-surgical treatments grew by 44% in 2021. Women represented 94% of all procedures, with breast augmentation being the most common surgical procedure. North America's market leadership is further bolstered by regulatory approvals and innovation from major players like Solta Medical Inc. and Candela Corporation.

Emerging markets, particularly in Asia Pacific and Latin America, are witnessing rapid growth due to increasing disposable incomes and growing aesthetic awareness. Countries like Brazil and South Korea are seeing a surge in cosmetic procedures, driven by cultural shifts and improved access to advanced treatments. These regions present significant opportunities for market expansion as healthcare infrastructure improves and consumer demand rises.

Unlicensed Facilities Threaten Industry Growth

The presence of an unregulated market segment poses a significant challenge to the cosmetic surgery industry. The proliferation of unlicensed medical spas and non-certified practitioners, particularly in countries like Brazil, South Korea, and the United States, has led to an increase in substandard procedures and botched surgeries. These facilities often use inferior products and lack qualified professionals, undermining consumer trust and market credibility. Regulatory bodies are working to address these issues, but the persistence of illicit vendors remains a hurdle to sustained market growth.

Major Companies:

Major companies working towards the market's growth include Solta Medical Inc. (Bausch Health Companies), Candela Corporation, Cynosure Lutronic, Galderma, Johnson and Johnson, Tiger Aesthetics Medical, LLC, Sinclair, POLYTECH Health & Aesthetics GmbH, Implantech, Batavia Biosciences, among others.

Recent Developments:

  • In August 2025, ELIXIR MD, Inc. announced the establishment of a wholly owned subsidiary in Australia and New Zealand. As part of this expansion, the company also entered into an exclusive partnership with High Tech Medical Pty Ltd. to introduce the ELIXIR MD device throughout the region.
  • In July 2025, Apyx Medical Corporation launched its Renuvion device in China as part of its global expansion strategy. The rollout is supported by a distribution agreement with GlamMoon Medical Technology, a subsidiary of BeauCare Clinics Investment Co., Ltd., following initial market clearance from China's National Medical Products Administration.

Related Reports:

Laser-Assisted Liposuction Market is segmented By Product Type (Portable Liposuction Surgery Devices, Standalone Liposuction Surgery Devices), By Technology (Suction-Assisted Liposuction, Power-Assisted Liposuction, Water Jet Assisted Liposuction Devices, Twin Cannula-Assisted Liposuction, Radiofrequency, Assisted Liposuction Devices, Others), By Application (Hospitals, Ambulatory Centers, Cosmetic Surgical Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Breast Implant Market is segmented By Type (Silicone Breast Implants, Saline Breast Implants), By Application (Reconstructive Surgery, Cosmetic Surgery), By End-User (Hospitals, Cosmetology Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Buttock Augmentation Market is segmented By Type (Buttock Implants, Buttock Injections, Other), By End User (Hospitals, Aesthetic Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031

About DataM Intelligence 4Market Research:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others.

Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market, by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

To find out more, visit https://datamintelligence.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Content Source: https://www.datamintelligence.com/research-report/cosmetic-surgery-market
Visit Our Website: https://datamintelligence.com

Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cosmetic-surgery-market-size-worth-us-73-09-billion-by-2033-with-7-9-cagr-report-by-datam-intelligence-302538860.html

© 2025 PR Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.